02:27 PM EDT, 04/25/2024 (MT Newswires) -- Bausch + Lomb ( BLCO ) said Thursday that a clinical study of a daily nutritional supplement for dry eyes met primary endpoints in tear production and in ocular symptoms.

The study also achieved secondary endpoints with statistically significant improvements in tear-film break-up time, osmolarity, ocular surface health and presence of an inflammatory marker, the firm said. The results were published in Frontiers in Ophthalmology.

Bausch + Lomb ( BLCO ) said it expects to launch the supplement under the brand name Blink NutriTears in early Q3 in the US.